Through
1/1
Penn biologist to discuss the science—and politics—behind GMOs
During the 1980s, Andrew Binns, now a professor in the School of Arts & Sciences’ Department of Biology and interim dean of the College of Arts & Sciences, helped lay the scientific groundwork that enable
Penn Vet’s diagnostic labs help keep diseases at bay
[vimeo]199040501[/vimeo]
Penn vets share stories of working dogs at Ground Zero after 9/11
The Sept. 11, 2001, attacks didn’t just take the lives of nearly 3,000 people, they also irreversibly affected the lives of tens of thousands more, including survivors, victims’ families, first responders, and recovery workers.
Penn Vet Research Identifies New Target for Taming Ebola
Viruses and their hosts are in a eternal game of one-upmanship. If a host cell evolves a way to stop a virus from spreading, the virus will look for a new path. And so on and so forth.
Penn Paleobiologist Lauren Sallan Selected as a 2017 TED Fellow
The University of Pennsylvania’s Lauren Sallan, an assistant professor in the School of Arts & Sciences’ Department of Earth and Environmental Science, has been selected as a
Penn Student-Athlete Arabella Uhry Explores the Financial Side of Health Care
At 7 years old, Arabella Uhry, now a junior at the University of Pennsylvania, developed a relationship that sparked her interest in health care.
Penn: Epigenetic Change Ties Mitochondrial Dysfunction to Tumor Progression
Mitochondria, the mighty energy factories of the cell, often malfunction in cancer, as well as in other conditions such as aging, neurodegenerative disease and heart disease. Whether these changes in mitochondria actually contribute to the spread of cancer, however, has been controversial.
Penn Study Finds Link Between HIV Treatment and Neuronal Degeneration
Antiretroviral drugs have been life-changing therapies for HIV patients, but they can have significant side effects.
How HIV/AIDS treatment affects the brain
When it comes to treating HIV/AIDS, antiretroviral drugs such as protease inhibitors can present a double-edged sword. “Protease inhibitors are very effective antiviral therapies, but they do have inherent toxicities,” says Kelly Jordan-Sciutto